Multiple Myeloma, Refractory Clinical Trials in Cleveland, Ohio
2 recruitingCleveland, Ohio
Showing 1–2 of 2 trials
Recruiting
Phase 2
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
CellCentric Ltd.100 enrolled20 locationsNCT07096778
Recruiting
Phase 1
LMY-920 for Treatment of Relapsed or Refractory Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Luminary Therapeutics30 enrolled1 locationNCT05546723